Global biodetectors and accessories
market is expected to reach USD 14.9 billion by 2022, according to a new
study by Grand View Research, Inc.Increasing prevalence of airborne and contact
diseases such as anthrax, coronavirus, and plague is a high impact rendering
driver of biodetectors and accessories market.
According to
the World Health Organization (WHO),plague is a severe air-borne disease with
casefatality ratio of 30%-60% and there were 783 cases reported globally in
2013. Moreover, continuous deterioration of environmental conditions as a consequence
of increasing pollution is anticipated to induce demand for biodetectors and
accessories market.
Furthermore,
the advent of technologically-advanced products such as microfluidics-based
detectors, micro arrays, PCR, and electrochemiluminescence-based devices is
anticipated to propel demand for biodetectors in a wide range of applications,
thereby fueling growth of overall market over the forecast period. For
instance, in November 2015, Smiths Detection launched TRACE-PRO, probe-based
non-radioactive explosives detector.
This product
exhibited enhanced speed and increased efficiency of the sample screening. The
aforementioned factors are expected to serve as key contributing factors
towards growth of biodetectors and accessories market over the forecast period.
To request a
sample copy or view summary of this report, click the link below:
Further key findings from the study suggest:
- In 2014, instruments dominated the product segment, accounting for a revenue share of over 35.0%, owing to its incorporation in a wide range of applications such as biohazard detection, pharmaceutical research, and forensic sciences
- The clinical applications market held a substantial share constituting of over 44.0% of the overall revenue owing to rising incorporation of biodetector kits & reagents in DNA analysis, human cell identification, laboratory-based pathogen testing, and toxin detection and identification.
- Point of care testing dominated the end-use segment as a consequence of rising penetration of these devices in medical analytics, toxicology, drug screening, and rapid diagnosis of heart diseases through detection of biomarkers. Other end-use segment inclusive of biodefense is anticipated to be the fastest growing market owing to rising R&D investments in chemical detection systems coupled with high threat of bioterrorism and disease outbreaks.
- Some key players catering to this industry are BioDetection Instruments, Inc., PositiveID Corporation, BioDetection Systems, Bertin Technologies, BBI Detection,Smith Detection, MSA the Safety Company, Research International, Shimadzu Corporation, Agilent Technologies, Bio Rad Laboratories, Thermo Fisher Scientific, Response BioMedical, Corp.,Physical Sciences, Inc., NetBio, Inc., andMBio Diagnostics, Inc.
- New product development in an attempt to cater to the changing consumer requirements, is a viable sustainability strategy adopted by these market participants. For instance, in November 2015, PositiveID Corporation developed “New Firefly Dx Prototype System” with enhanced PCR capabilities enabling the detection of multiple pathogens in lower quantities.
See More
Reports of This Category:
About
Grand View Research:
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email:
sales@grandviewresearch.com
No comments:
Post a Comment